Associate Director, Global Market Access & Pricing

Company: Alnylam Pharmaceuticals
Location: Cambridge
Posted on: July 31, 2022

Job Description:

OverviewAlnylam is the world's leading RNA interference (RNAi) company. Founded in 2002, Alnylam was built upon a bold vision of turning scientific possibility into reality by harnessing the power of RNAi for human health as an innovative new class of medicines. We are a growing biopharmaceutical company with three approved medicines and a robust pipeline of investigational medicines focused in four strategic therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases, including several in late-stage development. Headquartered in Cambridge, Mass., Alnylam employs over 1,500 people in 19 countries and is rapidly growing globally, with additional offices in Norton, Mass., Maidenhead, U.K., Zug, Switzerland, Amsterdam, Netherlands, and Tokyo, Japan. Alnylam is proud to have been recognized as one of The Boston Globe's Top Places to Work six years in a row (2015-2020), a Great Place to Work in the U.K. and Switzerland two years in a row (2019-2020) and a Science Magazine's Top Employer two years in a row (2019-2020). Please visit www.alnylam.com for more information.The Assoc Director, Global Market Access and Pricing will be responsible for Alnylam's global pricing, reimbursement and market access responsibilities associated with programs in acute hepatic porphyria (AHP) and primary hyperoxaluria type 1 (PH1). This role will report to the VP Global Market Access & Pricing and will be a key member of the Global Market Access & Pricing team.Summary of Key Responsibilities Act as Market Access lead to Global Medical, Access and Commercial teams to develop and execute on strategic pricing and market access strategy for inline products consistent with Alnylam's patient access/pricing philosophy and our pricing policy and practices. Represent Market Access to Leadership Teams for AHP and PH1 and ensure proper consideration to payer and access needs in strategic decision-making. Closely working with the VP Global Market Access & Pricing, regions and key markets (US, EU4, UK, Japan and Brazil), to maximize assets while securing meaningful access to patients both in direct Alnylam markets as well as Distributor markets. Ensure market access decisions adequately consider cross border implications (including International Referencing Pricing risk). Develop and lead strategic pricing/value framework decisions for ultra-rare/rare disease assets through highly integrated global/regional/local commercial teams. Working with regional partners, maintain and monitor price decisions across countries to ensure alignment with global pricing strategy. Lead in alignment with Alnylam's Patient Access Philosophy by further improving VBAs (Value Based Agreements). Monitor global pricing and market access trends and identify opportunities for novel payer engagement. Collaborate and maintain relationships with key internal partners, including Marketing, Medical Affairs, Value and Evidence Strategy, New Product Commercialization, Competitive Intelligence, Market Insights, and others as necessary.Qualifications At least 7+ years of biopharmaceutical industry experience in leadership positions of increasing responsibility. Advanced degree in relevant discipline preferred. Minimum of 7 years Market Access experience, at global or regional level. Strong experience working cross-functionally/regionally to develop pricing and reimbursement strategies both in the US and globally. Strong ability to understand market trends, financial data, and customer needs with strong acumen assessing competitive intelligence data. Previous direct experience with launch/post-launch Market Access planning and strategy building required. Experience with indication expansion and Lifecycle Management preferred. Recent experience launching transformational products in orphan indications preferred. Demonstrated success in managing competing priorities and working in a fast-paced environment. If employed in the U.S., being fully vaccinated against COVID-19 as defined by the Centers for Disease Control and Prevention (CDC) is required.Alnylam Pharmaceuticals is an EEO employer committed to an exciting, diverse, and enriching work environment.

Keywords: Alnylam Pharmaceuticals, Cambridge , Associate Director, Global Market Access & Pricing, Executive , Cambridge, Massachusetts